Understanding Immunotherapy and it's Impact on Ovarian Cancer

Поделиться
HTML-код
  • Опубликовано: 7 ноя 2022
  • Runsi Sen, Founder of ‪@Ovarcome‬ in conversation with Dr. Rod Rocconi, Professor, University of Alabama at Birmingham

Комментарии • 4

  • @Ovarcome
    @Ovarcome  Год назад

    Any questions will be addressed by Dr. Rocconi - please type here and we will respond to it here, thank you!

  • @Ovarcome
    @Ovarcome  Год назад

    If you have any questions, please type in the comments section - thank you!

  • @tinastavredes3780
    @tinastavredes3780 Год назад +1

    Are there vaccines for 3rd occurrence of ovarian cancer?

    • @Ovarcome
      @Ovarcome  Год назад

      Hello Tina, thank you for watching! Here is the response from Dr. Rocconi:
      "Not currently. We did publish a paper of a phase 1 trial evaluating VIGIL + immunotherapy in recurrent ovarian cancer. although small numbers and early phase, the response rates and side effects were promising. hopefully will have further similar clinical trials in the future. "